Rothschild & Co Asset Management US’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-15,524
Closed -$1.12M 598
2017
Q1
$1.12M Sell
15,524
-1,141
-7% -$75.5K 0.01% 361
2016
Q4
$953K Buy
16,665
+13,682
+459% +$1.25M 0.01% 391
2016
Q3
$382K Buy
2,983
+61
+2% +$7.81K 0.01% 509
2016
Q2
$364K Buy
+2,922
New +$336K 0.01% 522

Other funds holding ELGX

Rothschild & Co Asset Management US's ELGX Position: Q2 2017 in Review

Rothschild & Co Asset Management US sold out of Endologix Inc (ELGX) in Q2 2017, closing a stake of 15,524 shares — an estimated $1.12M sold.

Rothschild & Co Asset Management US first reported a position in ELGX in Q2 2016 and held it in 4 quarters. The position peaked at $1.12M in Q1 2017. 111 funds tracked by Wall St. Rank hold ELGX as of Q2 2017.

  • Rothschild & Co Asset Management US reported no remaining Endologix Inc position as of Q2 2017 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 15,524 Endologix Inc shares in Q2 2017, an estimated $1.12M.
  • Rothschild & Co Asset Management US first reported a position in Endologix Inc in Q2 2016 and held it in 4 quarters.
  • Rothschild & Co Asset Management US's Endologix Inc position peaked at $1.12M in Q1 2017.
  • 111 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2017.

Based on Rothschild & Co Asset Management US's 13F filing for Q2 2017, filed 27 Jul 2017.